Literature DB >> 17671005

Health-care costs associated with amputation or reconstruction of a limb-threatening injury.

Ellen J MacKenzie1, Alison Snow Jones, Michael J Bosse, Renan C Castillo, Andrew N Pollak, Lawrence X Webb, Marc F Swiontkowski, James F Kellam, Douglas G Smith, Roy W Sanders, Alan L Jones, Adam J Starr, Mark P McAndrew, Brendan M Patterson, Andrew R Burgess.   

Abstract

BACKGROUND: Recent reports have suggested that functional outcomes are similar following either amputation or reconstruction of a severely injured lower extremity. The goal of this study was to compare two-year direct health-care costs and projected lifetime health-care costs associated with these two treatment pathways.
METHODS: Two-year health-care costs were estimated for 545 patients with a unilateral limb-threatening lower-extremity injury treated at one of eight level-I trauma centers. Included in the calculation were costs related to (1) the initial hospitalization, (2) all rehospitalizations for acute care related to the limb injury, (3) inpatient rehabilitation, (4) outpatient doctor visits, (5) outpatient physical and occupational therapy, and (6) purchase and maintenance of prosthetic devices. All dollar figures were inflated to constant 2002 dollars with use of the medical service Consumer Price Index. To estimate projected lifetime costs, the number of expected life years was multiplied by an estimate of future annual health-care costs and added to an estimate of future costs associated with the purchase and maintenance of prosthetic devices.
RESULTS: When costs associated with rehospitalizations and post-acute care were added to the cost of the initial hospitalization, the two-year costs for reconstruction and amputation were similar. When prosthesis-related costs were added, there was a substantial difference between the two groups ($81,316 for patients treated with reconstruction and $91,106 for patients treated with amputation). The projected lifetime health-care cost for the patients who had undergone amputation was three times higher than that for those treated with reconstruction ($509,275 and $163,282, respectively).
CONCLUSIONS: These estimates add support to previous conclusions that efforts to improve the rate of successful reconstructions have merit. Not only is reconstruction a reasonable goal at an experienced level-I trauma center, it results in lower lifetime costs.

Entities:  

Mesh:

Year:  2007        PMID: 17671005     DOI: 10.2106/JBJS.F.01350

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  58 in total

1.  Patients with unilateral transfemoral amputation treated with a percutaneous osseointegrated prosthesis: a cost-effectiveness analysis.

Authors:  E Hansson; K Hagberg; M Cawson; T H Brodtkorb
Journal:  Bone Joint J       Date:  2018-04-01       Impact factor: 5.082

2.  Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.

Authors:  Ira L Leeds; Vasanthkumar Namasivayam; Assanatou Bamogo; Prithvi Sankhla; Winter M Thayer
Journal:  Am J Prev Med       Date:  2018-12-17       Impact factor: 5.043

3.  Proximal tibial metaphyseal fractures with severe soft tissue injury: clinical and functional results at 2 years.

Authors:  James S Starman; Renan C Castillo; Michael J Bosse; Ellen J MacKenzie
Journal:  Clin Orthop Relat Res       Date:  2009-10-28       Impact factor: 4.176

Review 4.  [Limb salvage or amputation after severe trauma to the lower extremities : Evidence from the LEAP Study].

Authors:  C W Müller; C Krettek; S Decker; S Hankemeier; N Hawi
Journal:  Unfallchirurg       Date:  2016-05       Impact factor: 1.000

Review 5.  Current Concepts and Ongoing Research in the Prevention and Treatment of Open Fracture Infections.

Authors:  Geoffrey D Hannigan; Nicholas Pulos; Elizabeth A Grice; Samir Mehta
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-01-01       Impact factor: 4.730

6.  Trends in Pediatric Traumatic Upper Extremity Amputations.

Authors:  Venus Vakhshori; Gabriel J Bouz; Cory K Mayfield; Ram K Alluri; Milan Stevanovic; Alidad Ghiassi
Journal:  Hand (N Y)       Date:  2018-05-30

7.  Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

Authors:  Adam P Goode; William J Richardson; Robin M Schectman; Timothy S Carey
Journal:  Spine J       Date:  2013-12-07       Impact factor: 4.166

8.  Functional analysis of limb recovery following autograft treatment of volumetric muscle loss in the quadriceps femoris.

Authors:  Mon Tzu A Li; Nick J Willett; Brent A Uhrig; Robert E Guldberg; Gordon L Warren
Journal:  J Biomech       Date:  2013-11-11       Impact factor: 2.712

9.  A cost-utility analysis of amputation versus salvage for Gustilo type IIIB and IIIC open tibial fractures.

Authors:  Kevin C Chung; Daniel Saddawi-Konefka; Steven C Haase; Gautam Kaul
Journal:  Plast Reconstr Surg       Date:  2009-12       Impact factor: 4.730

10.  The utility of scores in the decision to salvage or amputation in severely injured limbs.

Authors:  Rajasekaran Shanmuganathan
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.